•
Sep 30, 2020

ImmunityBio Q3 2020 Earnings Report

Total Revenue
$151K
Previous year: $12K
+1158.3%
EPS
-$0.41
Previous year: -$0.16
+156.2%
Gross Profit
$151K
Previous year: $12K
+1158.3%
Cash and Equivalents
$84.7M
Free Cash Flow
-$20M
Total Assets
$181M

ImmunityBio

ImmunityBio

ImmunityBio Revenue by Segment